We are excited to share updated overall survival data from our ongoing Phase 2a trial of atebimetinib in combination with mGnP in first-line pancreatic cancer patients,” said Ben Zeskind, Ph.D., ...

Researchers have developed a powerful new method to simulate and predict how cracks form and grow in engineering materials ...

End-of-Phase 2 interactions with FDA complete; scientific advice received from EMA - - Company expects to dose first patient in global Phase 3 registrational trial, MAPKeeper 301, in mid-2026 - - Over ...

Through a recent notice, the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has ...

Some gun show deals look tempting, but certain models come with safety issues, poor parts, or hidden costs. Know what to skip ...

Geologist Peter Malin and his former graduate student, Allen Hunt, suggest that the growing weight of the ice sheet would have triggered quakes by causing periodic crustal failure along what is now ...

Detailed price information for Oncotelic Therapeutics Inc (OTLC) from The Globe and Mail including charting and trades.

Highlighting recent advancements in ceramic AM that are coming out of academic labs and are influencing the future of the ...

In the new study, scientists gave the drug to mice that were overweight and unhealthy. Even though the mice didn’t eat less ...

A new study from Johns Hopkins Medicine has found something very surprising. A drug originally made to treat Alzheimer’s ...

Groundwater is rarely static. Its level and flow change throughout the year due to rainfall patterns, temperature variation, irrigation, nearby construction activity, and natural drainage ...